These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 21791203)
21. KAI1 protein is down-regulated during the progression of human breast cancer. Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724 [TBL] [Abstract][Full Text] [Related]
22. A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient. Zhou J; Trock B; Tsangaris TN; Friedman NB; Shapiro D; Brotzman M; Chan-Li Y; Chan DW; Li J Breast Cancer Res Treat; 2010 Aug; 123(1):73-86. PubMed ID: 19902353 [TBL] [Abstract][Full Text] [Related]
23. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240 [TBL] [Abstract][Full Text] [Related]
24. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
25. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
26. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238 [TBL] [Abstract][Full Text] [Related]
27. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Guerreiro Da Silva ID; Hu YF; Russo IH; Ao X; Salicioni AM; Yang X; Russo J Int J Oncol; 2000 Feb; 16(2):231-40. PubMed ID: 10639564 [TBL] [Abstract][Full Text] [Related]
28. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
29. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Kelly T; Kechelava S; Rozypal TL; West KW; Korourian S Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365 [TBL] [Abstract][Full Text] [Related]
30. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Wykoff CC; Beasley N; Watson PH; Campo L; Chia SK; English R; Pastorek J; Sly WS; Ratcliffe P; Harris AL Am J Pathol; 2001 Mar; 158(3):1011-9. PubMed ID: 11238049 [TBL] [Abstract][Full Text] [Related]
31. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070 [TBL] [Abstract][Full Text] [Related]
32. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas. Soriano Z; Pardee JD Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969 [TBL] [Abstract][Full Text] [Related]
34. The HCCR oncoprotein as a biomarker for human breast cancer. Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390 [TBL] [Abstract][Full Text] [Related]
35. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Rabban JT; Koerner FC; Lerwill MF Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976 [TBL] [Abstract][Full Text] [Related]
36. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues. Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919 [TBL] [Abstract][Full Text] [Related]
37. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis. Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806 [TBL] [Abstract][Full Text] [Related]
38. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Leo C; Faber S; Hentschel B; Höckel M; Horn LC Ann Diagn Pathol; 2006 Dec; 10(6):327-32. PubMed ID: 17126249 [TBL] [Abstract][Full Text] [Related]
39. Tumor endothelial marker 8 expression in triple-negative breast cancer. Gutwein LG; Al-Quran SZ; Fernando S; Fletcher BS; Copeland EM; Grobmyer SR Anticancer Res; 2011 Oct; 31(10):3417-22. PubMed ID: 21965755 [TBL] [Abstract][Full Text] [Related]
40. Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade. Fonseca-Sánchez MA; Rodríguez Cuevas S; Mendoza-Hernández G; Bautista-Piña V; Arechaga Ocampo E; Hidalgo Miranda A; Quintanar Jurado V; Marchat LA; Alvarez-Sánchez E; Pérez Plasencia C; López-Camarillo C Int J Oncol; 2012 Aug; 41(2):670-80. PubMed ID: 22614840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]